Mumbai
February 14, 2019 - A new report published by Research on Global Markets titled "Global Multiplex Biomarker Imaging Market (2018-2023)" studies the performance of the global multiplex biomarker imaging market over a five year period from 2018 to 2023. The report comprises the value forecast of the global multiplex biomarker imaging market and offers insights into the factors driving as well as restricting market growth. According to the report, the global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018–2023 period, generating a revenue of USD 523.59Mn by 2023.

The global multiplex biomarker imaging market is segmented based on component type, imaging technique, application and end-user.

Within the imaging technique segment, immunohistochemistry (IHC) currently holds the largest market share due to its widespread usage in research laboratories and clinical diagnostics.

Among components, instruments currently holds the largest market share. However, software is anticipated to witness the highest growth during the forecast period.

In terms of applications, multiplex biomarker imaging products are used widely in oncology studies, followed by medicinal safety applications, which is expected to expand at a CAGR of 14.1% during 2018–2023.

Research on Global Markets tracks the performance of the global multiplex biomarker imaging market across the key geographies of North America, Latin America, Europe, Asia Pacific, and Middle East and Africa. According to the report, North America dominated the global multiplex biomarker imaging market with a share of 50% in 2017, followed by Europe with a 28% share. Asia-Pacific is expected to expand at the highest CAGR (16.0%) during 2018–2023.

Key highlights of the report:
Scope and segmentation of the global multiplex biomarker imaging market
A comprehensive overview of the historical, current and predicted market size, revenue and attractiveness
Market segmentation and analysis based on the imaging techniques – immunohistochemistry, fluorescent in-situ hybridization, immunofluorescence, toponome imaging system and tissue microarray
Market segmentation and analysis based on components – kits, instruments, reagents and software
Market segmentation and analysis based on application and usage – medicinal safety, oncology, protein research ad neurodegeneration
Regional market analysis of North America, Asia-Pacific, Europe, Latin America, and the Middle East and Africa
The report also includes some of the key players operating in the global multiplex biomarker imaging market such as Perkin Elmer, Inc., Bio-rad Laboratories Inc., Thermo Fisher Scientific, Inc., Abcam plc., Merck KGaA, Illumina Inc., Leica Biosystems Nussloch GmbH, Ventana Medical Systems, Inc., Aushon BioSystems Ltd., MicroConstants, Inc. and ToposNomos Ltd.

For more information, download Global Multiplex Biomarker Imaging Market:
https://www.researchonglobalmarkets.com/global-multiplex-biomarker-imaging-market-2018-2023.html

Owned by Netscribes, Research on Global Markets is the go-to platform for global professionals looking for credible and transparent research on developed and emerging markets. We set ourselves apart from other online market research publishers with our focused coverage, commitment to data authenticity, simple licensing, and complete user privacy.

Please find below media contact for the releases:
Name: Ejaz Ahmed
Email: [email protected]
US Toll-Free: 18888313350
M: +8450829337